Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

An image of a group of women in India wearing masks.

India Needs to Focus on Three Urgent Actions to Mitigate its COVID-19 Humanitarian Crisis

India’s second COVID-19 wave has been explosive, reaching world record totals of over 300,000 daily officially reported cases. The true number is likely to be much higher, with a large number of cases missed as indicated by the delays in testing and rapidly rising positivity rates - currently one in every four people tested are positive for COVID-19 across India. Leading models estimate that there could be over 1 million cases per day. The health service has collapsed, with queues of ambulances parked outside full hospitals, oxygen and drug shortages in multiple states, and life-saving non-COVID services interrupted.

A figure of the summary of costs and consequences to consider in COVID-19 vaccine HTA.

Who Gets a COVID-19 Vaccine and Who Pays? The Need for Economic Analysis

In 2020, epidemiological modelling went from relative obscurity to being central in helping governments, and the public, understand COVID-19 as it spread around the world. In 2021, with the emergence of effective COVID-19 vaccines, Health Technology Assessment (HTA) will be critical to making the best possible decisions in bringing the pandemic under control, particularly in low-and middle-income countries (LMICs). In this blog we look at the potential of HTA to inform how much vaccine countries should buy, who should pay, and how vaccines can be most effectively delivered.